Blog Posts Discuss U.S.-Sponsored Zika Vaccine Trial, Importance Of Health Systems Strengthening In Outbreak Response
Center for Global Health Policy’s “Science Speaks”: While “August is the new September” in accelerated Zika vaccine quest, funding gap could slow momentum, Fauci says
Antigone Barton, senior editor and writer of “Science Speaks,” discusses the launch of a Zika candidate vaccine clinical trial, writing, “The Aug. 1 start puts the phase one clinical trial a month ahead of schedule, the National Institute of Allergy and Infectious Diseases [D]irector [Anthony Fauci] said. But, he added that a continued lack of dedicated funding for Zika research will slow necessary ground work for testing the candidate further in Zika-endemic countries…” (8/3).
U.S. Global Leadership Coalition: Colombia Shows We Can Fight Zika — If We Have the Resources
David Stein, policy associate at USGLC, discusses the importance of U.S. collaboration with developing countries to improve their health care systems. He writes, “The success achieved in Colombia [in declaring an end to its Zika epidemic] — and the threat posed by Zika to the U.S. — highlights the importance of the president’s emergency supplemental funding request to combat Zika, currently awaiting the return of members of Congress from their summer recess. … In other words, helping developing countries strengthen their own internal health systems is not only the right thing to do; it is also the smart thing to do for America’s health security” (8/3).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.